Skip to main content
IMPACT BIOMEDICAL INC. logo

IMPACT BIOMEDICAL INC. — Investor Relations & Filings

Ticker · IBO ISIN · US45259L2051 US Professional, scientific and technical activities
Open in API
Filings indexed 121 across all filing types
Latest filing 2026-04-22 Regulatory Filings
Country US United States of America
Listing US IBO

About IMPACT BIOMEDICAL INC.

https://www.impactbiomedinc.com/

Impact Biomedical Inc. is a biotechnology company that discovers, validates, patents, and develops science and technologies into innovative solutions for human health and wellness. Operating under the principle "Inspired by Nature, Powered by Science," the company focuses on creating new offerings and treatment options to address unmet healthcare needs. Its activities include the development of products in specialty biopharmaceuticals and the acquisition of technologies designed to protect against pathogens.

Recent filings

Filing Released Lang Actions
S-8 POS - IMPACT BIOMEDICAL INC. (0001834105) (Filer)
Regulatory Filings
2026-04-22 English
S-8 POS - IMPACT BIOMEDICAL INC. (0001834105) (Filer)
Capital/Financing Update Classification · 95% confidence The document is a Post-Effective Amendment No. 1 to a Registration Statement on Form S-8 filed with the SEC. It relates to the registration of shares under an employee equity incentive plan and includes a reoffer prospectus for resale of shares by selling stockholders. The document is a regulatory filing related to securities registration and resale, specifically under the Securities Act of 1933. It is not a financial report, earnings release, management discussion, or any other report type but rather a capital/financing update regarding share registration and resale. The Form S-8 and related prospectus are typical filings for employee stock plans and resale registration. Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length and content confirm it is a substantive filing, not a brief announcement or certification.
2026-04-06 English
4 - IMPACT BIOMEDICAL INC. (0001834105) (Issuer)
Director's Dealing
2026-03-26 English
8-K - IMPACT BIOMEDICAL INC. (0001834105) (Filer)
M&A Activity Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a Current Report used to announce major events that shareholders should know about. The content focuses on amendments to merger and share exchange agreements, voting and support agreements, and transition arrangement agreements. These amendments relate to merger transactions and share exchanges, including share issuances and funding obligations. The document does not contain full financial statements or detailed financial performance data but rather updates on merger-related agreements and corporate actions. Therefore, it is best classified under M&A Activity (TAR), which covers announcements and documents related to merger proposals or takeover bids.
2026-03-04 English
4
Director's Dealing
2026-01-06 English
DEF 14C
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a Schedule 14C Information Statement filed with the SEC, specifically titled as a Definitive Information Statement pursuant to Section 14(c) of the Securities Exchange Act of 1934. It details a corporate action approved by majority stockholders via written consent, specifically a reverse stock split. The document is not a proxy solicitation but an information statement notifying stockholders of the corporate action taken without a meeting. It includes detailed information about the voting securities, ownership, and the corporate action itself. This type of filing is an Information Statement under Schedule 14C, which is used to inform shareholders of corporate actions approved by written consent without a meeting. According to the filing definitions, this corresponds to Proxy Solicitation & Information Statement (PSI). The document is substantive and not merely an announcement or certification, so it is not Regulatory Filings (RNS) or Report Publication Announcement (RPA). Therefore, the correct classification is PSI with high confidence.
2025-12-30 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.